Go Deep
Lyka Labs Limited
Lyka Labs Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,164 | -29.1 | 2.84 | 0.54 | 72.65 |
| Oct 2026 | 20,482 | -29.1 | 2.84 | 0.54 | 72.65 |
Lyka Labs Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 423,094,000.0 | 280,307,000.0 | 307,280,000.0 | 366,605,000.0 |
| Net Profit | 20,652,000.0 | -76,068,000.0 | -3,000.0 | -33,574,000.0 |
| EPS | 0.6 | -2.1 | 0.0 | -0.9 |
Lyka Labs Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 1,284,446,000.0 | 1,384,954,000.0 | 1,051,323,000.0 | 883,390,000.0 | — |
| Net Profit | -100,318,000.0 | 80,120,000.0 | -24,894,000.0 | -132,119,000.0 | — |
| EPS | -2.8 | 2.2 | -0.8 | -4.6 | — |
Lyka Labs Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 1,745,364,000.0 | 1,762,060,000.0 | 1,568,555,000.0 | 1,515,228,000.0 | — |
| Total Liabilities | 837,050,000.0 | 726,241,000.0 | 885,900,000.0 | 1,058,521,000.0 | — |
| Total Equity | 923,935,000.0 | 1,035,502,000.0 | 681,544,000.0 | 454,406,000.0 | — |
Owes vs Owns
Lyka Labs Limited owed ₹0.48 for every ₹1 it owned in Mar 2026, down from ₹0.70 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.48× | 0.41× | 0.56× | 0.70× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Lyka Labs Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 4.0%Receivables 20.1%Inventory 7.8%Fixed assets (tangible) 47.1%Intangible assets 3.9%Long-term investments 9.0%Other assets 8.1%
How it's funded — Mar 2026
Short-term debt 14.5%Long-term debt 13.2%Payables 9.6%Other liabilities 10.6%Shareholders' equity 52.0%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 6.9 | 5.0 | 3.4 | 14.0 |
| Receivables | 35.0 | 43.1 | 27.0 | 20.1 |
| Inventory | 13.6 | 12.5 | 9.6 | 7.0 |
| Fixed assets (tangible) | 82.3 | 77.3 | 71.1 | 63.8 |
| Intangible assets | 6.7 | 9.2 | 11.9 | 20.7 |
| Long-term investments | 15.8 | 0.0 | 0.1 | 0.0 |
| Other assets | 14.2 | 29.1 | 33.8 | 26.0 |
| Liabilities & equity | ||||
| Short-term debt | 25.4 | 18.8 | 13.8 | 7.8 |
| Long-term debt | 23.0 | 18.1 | 41.8 | 62.3 |
| Payables | 16.8 | 15.0 | 12.1 | 9.4 |
| Other liabilities | 18.6 | 20.8 | 20.9 | 26.4 |
| Shareholders' equity | 90.8 | 103.6 | 68.3 | 45.7 |
| Net tangible assets | 85.7 | 94.3 | 56.2 | 24.8 |
Lyka Labs Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 52,428,000.0 | 18,994,000.0 | 17,734,000.0 | 89,526,000.0 | — |
| Investing Activities | -94,138,000.0 | -117,960,000.0 | -94,881,000.0 | 73,504,000.0 | — |
| Financing Activities | 41,861,000.0 | 52,920,000.0 | 19,528,000.0 | -216,427,000.0 | — |